首页 > 市场调查报告书 > 製药

临床实验

临床试验支援服务市场规模、份额和成长分析（按服务、阶段、研究设计、适应症、申办者和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898503

临床试验支援服务市场规模、份额和成长分析（按服务、阶段、研究设计、适应症、申办者和地区划分）－2026-2033年产业预测

Clinical Trials Support Services Market Size, Share, and Growth Analysis, By Service (Administrative Staff, Clinical Trial Site Management), By Phase, By Study Design, By Indication, By Sponsor, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，临床试验支援服务市场规模将达到 248.4 亿美元，到 2025 年将达到 268.3 亿美元，到 2033 年将达到 496.6 亿美元，预测期（2026-2033 年）的复合年增长率为 8%。

市场分析表明，临床试验支援服务在临床试验的成功开展和检测设计中发挥着至关重要的作用。这些服务包括研究药物的保管和储存、临床试验中心管理、药物剂量计算以及试剂盒管理监督等关键功能。新兴市场慢性病、感染疾病和热带病的高发生率导致创新药物需求激增，推动了该行业的快速成长。尤其值得一提的是，虚拟临床试验的普及应用已成为该行业收入成长的关键因素，它能够帮助研究机构提高效率并简化流程。此外，对病患招募和药物盲法的日益重视也进一步凸显了这些支持服务在推进临床研究和满足未被满足的需求方面的重要性。

临床试验支援服务市场驱动因素

临床试验支援服务市场的主要驱动力是感染疾病和慢性病发病率的上升趋势，以及製药公司大规模的研发投入。此外，受託研究机构（CRO）的兴起也显着促进了该行业的扩张。而且，对临床试验的需求不断增长，尤其是在新兴国家，这推动了对综合支援服务的需求。这些因素共同为临床试验的成长创造了有利环境，体现了透过有效的调查方法方法不断推进医疗保健解决方案和改善患者预后的努力。

临床试验支持服务市场的限制因素

临床试验支援服务市场的发展面临许多挑战，其中医疗基础设施和先进技术资源的匮乏尤为突出。此外，严格的病患招募规定和缺乏高效的试验管理系统也是限制该产业发展的主要障碍。然而，临床试验日益全球化，以及由研发驱动的持续技术创新，正为市场发展创造充满希望的机会。克服这些限制将释放新的潜力，为临床试验支援服务的未来发展奠定坚实的基础，并促进业界更有效率的合作与协作。

临床试验支援服务市场趋势

临床试验支援服务市场正经历显着成长，这主要得益于新兴国家对临床试验需求的不断增长以及製药公司研发投入的增加。随着专利到期给产业带来挑战，将临床试验外包给受託研究机构（CRO）的趋势日益明显，CRO的数量也不断增加以满足市场需求。这一趋势反映了製药业的策略转变，企业在研发过程中更加重视效率和成本效益，进一步加剧了全球临床试验服务市场的竞争。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Laboratory Corporation of America Holdings（LabCorp）（USA）
Charles River Laboratories International, Inc.（USA）
Syneos Health, Inc.（USA）
Parexel International Corporation（USA）
ICON plc（Ireland）
Wuxi AppTec Co., Ltd.（China）
Eurofins Scientific（Luxembourg）
ACM Global Laboratories（USA）
Clinipace Worldwide（USA）
Worldwide Clinical Trials（USA）
Premier Research（USA）
PSI CRO AG（Switzerland）
Novotech（Australia）
Velocity Clinical Research（USA）
Fortrea（USA）
CTI Clinical Trial and Consulting Services（USA）

结论与建议

简介目录

Product Code: SQMIG35D2068

Clinical Trials Support Services Market size was valued at USD 24.84 Billion in 2024 and is poised to grow from USD 26.83 Billion in 2025 to USD 49.66 Billion by 2033, growing at a CAGR of 8% during the forecast period (2026-2033).

Market insights indicate that clinical trials support services play a crucial role in the successful execution of clinical testing and assay design. These services encompass essential functions such as securing and storing research medications, managing clinical trial sites, calculating drug dosages, and overseeing kit management. The industry has seen a surge in demand for innovative pharmaceuticals, driven by the prevalence of chronic, infectious, and tropical diseases in emerging markets. Notably, the adoption of virtual clinical trials has emerged as a key factor in the sector's revenue growth, enabling research firms to enhance efficiency and streamline processes. Increased focus on patient recruitment and drug blinding further underscores the importance of these support services in advancing clinical research and meeting unmet therapeutic needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is primarily propelled by the increasing prevalence of infectious and chronic diseases, along with substantial research and development investments made by pharmaceutical companies. Additionally, the rise of contract research organizations has significantly contributed to this sector's expansion. Furthermore, there is a growing demand for clinical trials, especially in emerging nations, which enhances the need for comprehensive support services. These factors collectively create a robust environment for the growth of clinical trials, reflecting the ongoing commitment to advancing healthcare solutions and improving patient outcomes through effective research methodologies.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market faces challenges due to insufficient medical infrastructure and advanced technological resources. Furthermore, strict regulations concerning patient recruitment and the lack of efficient systems for trial management pose substantial barriers to the sector's development. However, the increasing globalization of clinical trials combined with ongoing technological innovations driven by research and development presents promising opportunities for market advancement. Addressing these constraints could unlock new potential and facilitate a more robust future for clinical trial support services, allowing for enhanced collaboration and efficiency in the industry.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is experiencing significant growth driven by increasing demand for trials in emerging economies, bolstered by heightened research and development investments from pharmaceutical companies. As the industry faces challenges from patent expirations, there is a shift towards outsourcing these trials to contract research organizations (CROs), which are proliferating in number to meet the demand. This trend reflects a strategic pivot in the pharmaceutical sector, where companies prioritize efficiency and cost-effectiveness in their R&D processes, further fueling the competitive landscape of clinical trial services on a global scale.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Clinical Trials Support Services Market Size by Service & CAGR (2026-2033)

Market Overview
Administrative Staff
Clinical Trial Site Management
- Patient Recruitment & Registry Services
- Patient Recruitment Management
- Patient Retention
Data Management
Institutional Review Boards

Global Clinical Trials Support Services Market Size by Phase & CAGR (2026-2033)

Market Overview
Phase I
Phase II
Phase III
Phase IV

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2026-2033)

Market Overview
Expanded Access
Interventional
Observational

Global Clinical Trials Support Services Market Size by Indication & CAGR (2026-2033)

Market Overview
Autoimmune or Inflammation
Cardiovascular
Diabetes
Oncology

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2026-2033)

Market Overview
Medical Devices
Pharmaceutical & Biopharmaceutical

Global Clinical Trials Support Services Market Size & CAGR (2026-2033)

North America (Service, Phase, Study Design, Indication, Sponsor)
- US
- Canada
Europe (Service, Phase, Study Design, Indication, Sponsor)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service, Phase, Study Design, Indication, Sponsor)
- Brazil
- Rest of Latin America
Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinipace Worldwide (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worldwide Clinical Trials (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PSI CRO AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novotech (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Velocity Clinical Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortrea (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CTI Clinical Trial and Consulting Services (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments